Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT TEMOZOLOMIDE 20MG CAPSULE Resolved 2020-01-30 2020-07-09 104922
ACT TERBINAFINE 250MG TABLET Resolved 2020-07-23 2020-09-24 120905
ACT TERBINAFINE 250MG TABLET Resolved 2023-06-19 2023-08-17 195629
ACT TERBINAFINE 250MG TABLET Resolved 2025-01-30 2025-01-30 249182
ACT TERBINAFINE 250MG TABLET Resolved 2020-04-10 2023-10-03 111874
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240028
ACT TERBINAFINE 250MG TABLET Resolved 2023-02-09 2023-07-05 184195
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240037
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-04-28 176860
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-01-18 176791
ALERTEC 100MG TABLET Resolved 2022-08-18 2022-09-23 167165
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2025-04-04 2025-10-10 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Actual shortage 2025-06-19 2025-12-18 260642
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2025-06-05 2025-12-11 259685
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LORAZEPAM 1MG TABLET Discontinued 2025-05-28 2025-05-28 258513
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-LOSARTAN/HCTZ 100MG 25MG TABLET Discontinued 2021-02-12 2021-02-12 133899
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
TEVA-MEDROXYPROGESTERONE 2.5MG TABLET Discontinued 2025-04-29 2025-04-29 256113
TEVA-MEDROXYPROGESTERONE 5MG TABLET Discontinued 2025-04-29 2025-04-29 256116
TEVA-MEDROXYPROGESTERONE 10MG TABLET Discontinued 2025-04-29 2025-04-29 256119
TEVA-METFORMIN 500MG TABLET Reversed 2025-05-28 2025-06-04 258452
TEVA-METFORMIN 850MG TABLET Reversed 2025-05-28 2025-06-04 258449
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258537
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258568
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258535
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Reversed 2025-05-28 2025-06-04 258532
TEVA-MODAFINIL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258732
TEVA-NAPROXEN 375MG TABLET Discontinued 2025-05-28 2025-05-28 258493
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055